4-[2-[(3S,8R,9S,10R,13S,14R,17R)-17-[(2R,6R)-7-acetamido-6-methyl-3-oxoheptan-2-yl]-3-acetyloxy-10,13-dimethyl-1,2,3,4,7,8,9,11,12,14,15,17-dodecahydrocyclopenta[a]phenanthren-16-ylidene]hydrazinyl]-1-N,3-N-dihydroxybenzene-1,3-diamine oxide

C37H55N5O8 — CID 163154189

IUPAC4-[2-[(3S,8R,9S,10R,13S,14R,17R)-17-[(2R,6R)-7-acetamido-6-methyl-3-oxoheptan-2-yl]-3-acetyloxy-10,13-dimethyl-1,2,3,4,7,8,9,11,12,14,15,17-dodecahydrocyclopenta[a]phenanthren-16-ylidene]hydrazinyl]-1-N,3-N-dihydroxybenzene-1,3-diamine oxide
SMILESCC(=O)NC[C@H](C)CCC(=O)[C@H](C)[C@H]1C(=NNc2ccc([NH+]([O-])O)cc2[NH+]([O-])O)C[C@@H]2[C@H]3CC=C4C[C@@H](OC(C)=O)CC[C@]4(C)[C@H]3CC[C@@]21C
InChIInChI=1S/C37H55N5O8/c1-21(20-38-23(3)43)7-12-34(45)22(2)35-32(40-39-31-11-9-26(41(46)47)18-33(31)42(48)49)19-30-28-10-8-25-17-27(50-24(4)44)13-15-36(25,5)29(28)14-16-37(30,35)6/h8-9,11,18,21-22,27-30,35,39,41-42,46,48H,7,10,12-17,19-20H2,1-6H3,(H,38,43)/t21-,22+,27+,28+,29+,30-,35+,36+,37+/m1/s1
InChIKeyOLZANDPPZBDTLR-VESWDHSZSA-N
MW697.87 g/mol
LogP4.14
Rot. Bonds12

About 4-[2-[(3S,8R,9S,10R,13S,14R,17R)-17-[(2R,6R)-7-acetamido-6-methyl-3-oxoheptan-2-yl]-3-acetyloxy-10,13-dimethyl-1,2,3,4,7,8,9,11,12,14,15,17-dodecahydrocyclopenta[a]phenanthren-16-ylidene]hydrazinyl]-1-N,3-N-dihydroxybenzene-1,3-diamine oxide

4-[2-[(3S,8R,9S,10R,13S,14R,17R)-17-[(2R,6R)-7-acetamido-6-methyl-3-oxoheptan-2-yl]-3-acetyloxy-10,13-dimethyl-1,2,3,4,7,8,9,11,12,14,15,17-dodecahydrocyclopenta[a]phenanthren-16-ylidene]hydrazinyl]-1-N,3-N-dihydroxybenzene-1,3-diamine oxide (PubChem CID 163154189) has the molecular formula C37H55N5O8 and a molecular weight of 697.87 g/mol. Its IUPAC name is 4-[2-[(3S,8R,9S,10R,13S,14R,17R)-17-[(2R,6R)-7-acetamido-6-methyl-3-oxoheptan-2-yl]-3-acetyloxy-10,13-dimethyl-1,2,3,4,7,8,9,11,12,14,15,17-dodecahydrocyclopenta[a]phenanthren-16-ylidene]hydrazinyl]-1-N,3-N-dihydroxybenzene-1,3-diamine oxide.

Molecular Properties

Compound Name4-[2-[(3S,8R,9S,10R,13S,14R,17R)-17-[(2R,6R)-7-acetamido-6-methyl-3-oxoheptan-2-yl]-3-acetyloxy-10,13-dimethyl-1,2,3,4,7,8,9,11,12,14,15,17-dodecahydrocyclopenta[a]phenanthren-16-ylidene]hydrazinyl]-1-N,3-N-dihydroxybenzene-1,3-diamine oxide
PubChem CID163154189
Molecular FormulaC37H55N5O8
Molecular Weight697.87 g/mol
Exact Mass697.41
IUPAC Name4-[2-[(3S,8R,9S,10R,13S,14R,17R)-17-[(2R,6R)-7-acetamido-6-methyl-3-oxoheptan-2-yl]-3-acetyloxy-10,13-dimethyl-1,2,3,4,7,8,9,11,12,14,15,17-dodecahydrocyclopenta[a]phenanthren-16-ylidene]hydrazinyl]-1-N,3-N-dihydroxybenzene-1,3-diamine oxide
SMILESCC(=O)NC[C@H](C)CCC(=O)[C@H](C)[C@H]1C(=NNc2ccc([NH+]([O-])O)cc2[NH+]([O-])O)C[C@@H]2[C@H]3CC=C4C[C@@H](OC(C)=O)CC[C@]4(C)[C@H]3CC[C@@]21C
InChIInChI=1S/C37H55N5O8/c1-21(20-38-23(3)43)7-12-34(45)22(2)35-32(40-39-31-11-9-26(41(46)47)18-33(31)42(48)49)19-30-28-10-8-25-17-27(50-24(4)44)13-15-36(25,5)29(28)14-16-37(30,35)6/h8-9,11,18,21-22,27-30,35,39,41-42,46,48H,7,10,12-17,19-20H2,1-6H3,(H,38,43)/t21-,22+,27+,28+,29+,30-,35+,36+,37+/m1/s1
InChIKeyOLZANDPPZBDTLR-VESWDHSZSA-N
XLogP4.14
TPSA192.32 Ų
H-Bond Donors6
H-Bond Acceptors10
Rotatable Bonds12
Heavy Atoms50
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500697.87
LogP ≤ 54.14
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 1010

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}

Analyze 4-[2-[(3S,8R,9S,10R,13S,14R,17R)-17-[(2R,6R)-7-acetamido-6-methyl-3-oxoheptan-2-yl]-3-acetyloxy-10,13-dimethyl-1,2,3,4,7,8,9,11,12,14,15,17-dodecahydrocyclopenta[a]phenanthren-16-ylidene]hydrazinyl]-1-N,3-N-dihydroxybenzene-1,3-diamine oxide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 4-[2-[(3S,8R,9S,10R,13S,14R,17R)-17-[(2R,6R)-7-acetamido-6-methyl-3-oxoheptan-2-yl]-3-acetyloxy-10,13-dimethyl-1,2,3,4,7,8,9,11,12,14,15,17-dodecahydrocyclopenta[a]phenanthren-16-ylidene]hydrazinyl]-1-N,3-N-dihydroxybenzene-1,3-diamine oxide?
The IUPAC name of 4-[2-[(3S,8R,9S,10R,13S,14R,17R)-17-[(2R,6R)-7-acetamido-6-methyl-3-oxoheptan-2-yl]-3-acetyloxy-10,13-dimethyl-1,2,3,4,7,8,9,11,12,14,15,17-dodecahydrocyclopenta[a]phenanthren-16-ylidene]hydrazinyl]-1-N,3-N-dihydroxybenzene-1,3-diamine oxide (CID 163154189) is 4-[2-[(3S,8R,9S,10R,13S,14R,17R)-17-[(2R,6R)-7-acetamido-6-methyl-3-oxoheptan-2-yl]-3-acetyloxy-10,13-dimethyl-1,2,3,4,7,8,9,11,12,14,15,17-dodecahydrocyclopenta[a]phenanthren-16-ylidene]hydrazinyl]-1-N,3-N-dihydroxybenzene-1,3-diamine oxide.
What is the SMILES notation for 4-[2-[(3S,8R,9S,10R,13S,14R,17R)-17-[(2R,6R)-7-acetamido-6-methyl-3-oxoheptan-2-yl]-3-acetyloxy-10,13-dimethyl-1,2,3,4,7,8,9,11,12,14,15,17-dodecahydrocyclopenta[a]phenanthren-16-ylidene]hydrazinyl]-1-N,3-N-dihydroxybenzene-1,3-diamine oxide?
The canonical SMILES for 4-[2-[(3S,8R,9S,10R,13S,14R,17R)-17-[(2R,6R)-7-acetamido-6-methyl-3-oxoheptan-2-yl]-3-acetyloxy-10,13-dimethyl-1,2,3,4,7,8,9,11,12,14,15,17-dodecahydrocyclopenta[a]phenanthren-16-ylidene]hydrazinyl]-1-N,3-N-dihydroxybenzene-1,3-diamine oxide is CC(=O)NC[C@H](C)CCC(=O)[C@H](C)[C@H]1C(=NNc2ccc([NH+]([O-])O)cc2[NH+]([O-])O)C[C@@H]2[C@H]3CC=C4C[C@@H](OC(C)=O)CC[C@]4(C)[C@H]3CC[C@@]21C.
What is the InChIKey of 4-[2-[(3S,8R,9S,10R,13S,14R,17R)-17-[(2R,6R)-7-acetamido-6-methyl-3-oxoheptan-2-yl]-3-acetyloxy-10,13-dimethyl-1,2,3,4,7,8,9,11,12,14,15,17-dodecahydrocyclopenta[a]phenanthren-16-ylidene]hydrazinyl]-1-N,3-N-dihydroxybenzene-1,3-diamine oxide?
The InChIKey is OLZANDPPZBDTLR-VESWDHSZSA-N. The full InChI is InChI=1S/C37H55N5O8/c1-21(20-38-23(3)43)7-12-34(45)22(2)35-32(40-39-31-11-9-26(41(46)47)18-33(31)42(48)49)19-30-28-10-8-25-17-27(50-24(4)44)13-15-36(25,5)29(28)14-16-37(30,35)6/h8-9,11,18,21-22,27-30,35,39,41-42,46,48H,7,10,12-17,19-20H2,1-6H3,(H,38,43)/t21-,22+,27+,28+,29+,30-,35+,36+,37+/m1/s1.
What are the key properties of 4-[2-[(3S,8R,9S,10R,13S,14R,17R)-17-[(2R,6R)-7-acetamido-6-methyl-3-oxoheptan-2-yl]-3-acetyloxy-10,13-dimethyl-1,2,3,4,7,8,9,11,12,14,15,17-dodecahydrocyclopenta[a]phenanthren-16-ylidene]hydrazinyl]-1-N,3-N-dihydroxybenzene-1,3-diamine oxide?
4-[2-[(3S,8R,9S,10R,13S,14R,17R)-17-[(2R,6R)-7-acetamido-6-methyl-3-oxoheptan-2-yl]-3-acetyloxy-10,13-dimethyl-1,2,3,4,7,8,9,11,12,14,15,17-dodecahydrocyclopenta[a]phenanthren-16-ylidene]hydrazinyl]-1-N,3-N-dihydroxybenzene-1,3-diamine oxide has a molecular weight of 697.87 g/mol, XLogP of 4.14, 12 rotatable bonds, 6 hydrogen bond donors, and 10 hydrogen bond acceptors.
Where does this data come from?
All data for 4-[2-[(3S,8R,9S,10R,13S,14R,17R)-17-[(2R,6R)-7-acetamido-6-methyl-3-oxoheptan-2-yl]-3-acetyloxy-10,13-dimethyl-1,2,3,4,7,8,9,11,12,14,15,17-dodecahydrocyclopenta[a]phenanthren-16-ylidene]hydrazinyl]-1-N,3-N-dihydroxybenzene-1,3-diamine oxide is sourced from PubChem (CID 163154189), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).